483
Pharmalogic Los Angeles, LLCFDA 483 - Pharmalogic Los Angeles, LLC - February 05, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of PharmaLogic Los Angeles, LLC, a manufacturer of PET drugs, revealed a significant deficiency in their quality system. The firm failed to approve or reject processes and procedures before implementation, specifically regarding the visual inspection of PET drug products. This issue raises concerns about the adequacy of operator training and the ability to detect defects, potentially impacting drug identity, strength, quality, and purity.
Open in Dashboard
ID · f616832d-321c-4b48-9c6a-176290745154